• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

What next for reps?

Quote




Anonymous said:
I will admit alexion reps ave done well, but millionaire? No...
Click to expand...

Ok what do you think the most a rep could have made? If they are holding 15k in options alone which most of them are because of the split that's all they would need to have made a million pre-tax. That's not counting the ESPP, or annual incentive options. I know my Alexion rep well as we worked together at a previous company and he's a very honest guy and said he hit a million post tax with the run over $100.
 




Anonymous said:
Ok what do you think the most a rep could have made? If they are holding 15k in options alone which most of them are because of the split that's all they would need to have made a million pre-tax. That's not counting the ESPP, or annual incentive options. I know my Alexion rep well as we worked together at a previous company and he's a very honest guy and said he hit a million post tax with the run over $100.
Click to expand...

Bullshit
 












Similar threads

Eisai takes baton from Biogen as next Alzheimer's prospect follows in Aduhelm's footprints | FierceB
Replies
0
Views
639
Eisai
anonymous
Changes will announced to the company car policy next week.
Replies
10
Views
3K
Eisai
anonymous
Who will the next to "retire"?
Replies
30
Views
5K
Eisai
anonymous
What is next for OB?
Replies
46
Views
12K
Eisai
Anonymous
Aciphex patent expiry – next week?
Replies
9
Views
5K
Eisai
Anonymous
Top Bottom
Back
Quote